Ensembl ID ENSG00000115524 Gene ID 23451 Accession 10768
Gene Symbol SF3B1 Alias MDS;PRP10;Hsh155;PRPF10;SAP155;SF3b155 Full Name splicing factor 3b subunit 1
Position 2 : 197388515 - 197435079 Length 46565 bases Strand Minus strand
Status Confidence Main interacting RNAsmRNARBP type Canonical_RBPs
Summary This gene encodes subunit 1 of the splicing factor 3b protein complex. Splicing factor 3b, together with splicing factor 3a and a 12S RNA unit, forms the U2 small nuclear ribonucleoproteins complex (U2 snRNP). The splicing factor 3b/3a complex binds pre-mRNA upstream of the intron's branch site in a sequence independent manner and may anchor the U2 snRNP to the pre-mRNA. Splicing factor 3b is also a component of the minor U12-type spliceosome. The carboxy-terminal two-thirds of subunit 1 have 22 non-identical, tandem HEAT repeats that form rod-like, helical structures. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

ENSG00000115524 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000115524 SF3B1 -0.5 1.59e-13 KICH
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000115524 SF3B1 bladder cancer 21672358
ENSG00000115524 SF3B1 cancers 21995386
ENSG00000115524 SF3B1 acute myeloid leukemia (AML) 21998214
ENSG00000115524 SF3B1 cancer 22150006
ENSG00000115524 SF3B1 colorectal cancer 22496461
ENSG00000115524 SF3B1 tumor 22823977
ENSG00000115524 SF3B1 AML 22912701
ENSG00000115524 SF3B1 colon cancer 23113893
ENSG00000115524 SF3B1 tumor 23160465
ENSG00000115524 SF3B1 tumor 23205264
ENSG00000115524 SF3B1 tumors 23280334
ENSG00000115524 SF3B1 cancers 23300180
ENSG00000115524 SF3B1 tumor 23313955
ENSG00000115524 SF3B1 acute myeloid leukemia (AML) 23395771
ENSG00000115524 SF3B1 cancer 23594796
ENSG00000115524 SF3B1 AML 23645565
ENSG00000115524 SF3B1 tumor 23656622
ENSG00000115524 SF3B1 tumor 23714557
ENSG00000115524 SF3B1 cancer 23778141
ENSG00000115524 SF3B1 tumors 23793026
ENSG00000115524 SF3B1 tumor 23887304
ENSG00000115524 SF3B1 cancer 24302718
ENSG00000115524 SF3B1 tumour 24423917
ENSG00000115524 SF3B1 cancer 24623796
ENSG00000115524 SF3B1 cancers 24709888
ENSG00000115524 SF3B1 cancer 24764668
ENSG00000115524 SF3B1 AML 24781015
ENSG00000115524 SF3B1 Cancer 24795046
ENSG00000115524 SF3B1 cancer 24811221
ENSG00000115524 SF3B1 head and neck cancer 25139387
ENSG00000115524 SF3B1 AML 25220401
ENSG00000115524 SF3B1 AMLs 25331116
ENSG00000115524 SF3B1 tumor 25345442
ENSG00000115524 SF3B1 cancer 25376106
ENSG00000115524 SF3B1 acute myeloid leukemia (AML) 25412851
ENSG00000115524 SF3B1 breast cancer 25424858
ENSG00000115524 SF3B1 luminal breast cancer 25431237
ENSG00000115524 SF3B1 AML 25550361
ENSG00000115524 SF3B1 AML 25611784
ENSG00000115524 SF3B1 cancers 25768983
ENSG00000115524 SF3B1 tumor 25862704
ENSG00000115524 SF3B1 tumor 26068951
ENSG00000115524 SF3B1 cancer 26095796
ENSG00000115524 SF3B1 AML 26115659
ENSG00000115524 SF3B1 cancer 26171237
ENSG00000115524 SF3B1 Wilms tumor 26315090
ENSG00000115524 SF3B1 tumor 26331541
ENSG00000115524 SF3B1 tumour 26468443
ENSG00000115524 SF3B1 breast cancer 26490253
ENSG00000115524 SF3B1 pancreatic cancer 26498691
ENSG00000115524 SF3B1 tumours 26505679
ENSG00000115524 SF3B1 Mast Cell Tumors 26562302
ENSG00000115524 SF3B1 Cancer 26565915
ENSG00000115524 SF3B1 tumor 26626801
ENSG00000115524 SF3B1 AML 26643973
ENSG00000115524 SF3B1 cancer 26728853
ENSG00000115524 SF3B1 cancer 26742993
ENSG00000115524 SF3B1 cancer 26769193
ENSG00000115524 SF3B1 AML 26812887
ENSG00000115524 SF3B1 Cancer 26842708
ENSG00000115524 SF3B1 tumour 26847028
ENSG00000115524 SF3B1 breast cancer 26920143
ENSG00000115524 SF3B1 tumors 26923342
ENSG00000115524 SF3B1 tumors 26928227
ENSG00000115524 SF3B1 tumor 26933176
ENSG00000115524 SF3B1 cancer 27045317
ENSG00000115524 SF3B1 tumors 27116551
ENSG00000115524 SF3B1 tumor 27123562
ENSG00000115524 SF3B1 AML with recurrent genetic abnormalities 27137476
ENSG00000115524 SF3B1 cancer 27175787
ENSG00000115524 SF3B1 cancers 27211273
ENSG00000115524 SF3B1 breast cancer 27272679
ENSG00000115524 SF3B1 tumor 27315300
ENSG00000115524 SF3B1 cancer 27440103
ENSG00000115524 SF3B1 tumors 27486988
ENSG00000115524 SF3B1 cancer 27492256
ENSG00000115524 SF3B1 Cancer 27524419
ENSG00000115524 SF3B1 cancers 27604819
ENSG00000115524 SF3B1 cancer 27618338
ENSG00000115524 SF3B1 Cancer 27622329
ENSG00000115524 SF3B1 tumors 27660484
ENSG00000115524 SF3B1 cancer 27720643
ENSG00000115524 SF3B1 tumors 27800275
ENSG00000115524 SF3B1 AML 27983727
ENSG00000115524 SF3B1 tumor 28076841
ENSG00000115524 SF3B1 cancers 28087715
ENSG00000115524 SF3B1 tumors 28103691
ENSG00000115524 SF3B1 AML 28152414
ENSG00000115524 SF3B1 breast cancer 28177281
ENSG00000115524 SF3B1 cancer 28198434
ENSG00000115524 SF3B1 tumor 28229253
ENSG00000115524 SF3B1 tumors 28257297
ENSG00000115524 SF3B1 cancer 28296343
ENSG00000115524 SF3B1 cancers 28296713
ENSG00000115524 SF3B1 cancer 28304277
ENSG00000115524 SF3B1 malignant tumors 28409567
ENSG00000115524 SF3B1 cancer 28445500
ENSG00000115524 SF3B1 cancer 28503312
ENSG00000115524 SF3B1 lung cancer 28615231
ENSG00000115524 SF3B1 tumors 28618948
ENSG00000115524 SF3B1 colorectal cancer 28747380
ENSG00000115524 SF3B1 tumors 28810145
ENSG00000115524 SF3B1 cancer 28852199
ENSG00000115524 SF3B1 cancer 28884683
ENSG00000115524 SF3B1 colorectal cancer 28967088
ENSG00000115524 SF3B1 breast cancer 29023197
ENSG00000115524 SF3B1 tumors 29156643
ENSG00000115524 SF3B1 cancer 29235465
ENSG00000115524 SF3B1 tumors 29317634
ENSG00000115524 SF3B1 tumors 29327717
ENSG00000115524 SF3B1 colon cancer 29338026
ENSG00000115524 SF3B1 breast cancer 29383138
ENSG00000115524 SF3B1 cancer 29457796
ENSG00000115524 SF3B1 cancer 29463802
ENSG00000115524 SF3B1 tumor 29497459
ENSG00000115524 SF3B1 colorectal cancer 29641532
ENSG00000115524 SF3B1 metastatic tumors 29726589
ENSG00000115524 SF3B1 uveal tumors 29738114
ENSG00000115524 SF3B1 tumor 29755733
ENSG00000115524 SF3B1 cancer 29796163
ENSG00000115524 SF3B1 tumour 29796170
ENSG00000115524 SF3B1 breast cancer 29848666
ENSG00000115524 SF3B1 tumor 29954402
ENSG00000115524 SF3B1 tumors 29988936
ENSG00000115524 SF3B1 tumors 30073324
ENSG00000115524 SF3B1 cancer 30194306
ENSG00000115524 SF3B1 cancers 30295127
ENSG00000115524 SF3B1 gallbladder cancer 30304546
ENSG00000115524 SF3B1 cancer 30401776
ENSG00000115524 SF3B1 AML 30455953
ENSG00000115524 SF3B1 Cancer 30462273
ENSG00000115524 SF3B1 cancer 30462576
ENSG00000115524 SF3B1 tumours 30558566
ENSG00000115524 SF3B1 tumor 30581150
ENSG00000115524 SF3B1 cancer 30590765
ENSG00000115524 SF3B1 tumor 30605742
ENSG00000115524 SF3B1 cancer 30693020
ENSG00000115524 SF3B1 AML 30704227
ENSG00000115524 SF3B1 tumors 30719229
ENSG00000115524 SF3B1 AML 30795628
ENSG00000115524 SF3B1 AML 30813354
ENSG00000115524 SF3B1 cancer 30847022
ENSG00000115524 SF3B1 tumor 31024753
ENSG00000115524 SF3B1 tumour 31077629
ENSG00000115524 SF3B1 tumour 31109147
ENSG00000115524 SF3B1 cancer 31200327
ENSG00000115524 SF3B1 tumors 31320640
ENSG00000115524 SF3B1 AML 31334570
ENSG00000115524 SF3B1 prostate cancer 31344348
ENSG00000115524 SF3B1 tumors 31357599
ENSG00000115524 SF3B1 AML 31366893
ENSG00000115524 SF3B1 Cancer 31393856
ENSG00000115524 SF3B1 Tumors 31426461
ENSG00000115524 SF3B1 cancers 31466283
ENSG00000115524 SF3B1 cancers 31474574
ENSG00000115524 SF3B1 Cancer 31492682
ENSG00000115524 SF3B1 tumor 31561558
ENSG00000115524 SF3B1 cancer 31597163
ENSG00000115524 SF3B1 tumour 31597964
ENSG00000115524 SF3B1 cancer 31634348
ENSG00000115524 SF3B1 breast cancer 31666932
ENSG00000115524 SF3B1 cancer of the eye 31671564
ENSG00000115524 SF3B1 AML 31744877
ENSG00000115524 SF3B1 acute myeloid leukemia (AML) 31766606
ENSG00000115524 SF3B1 breast cancer 31919642
ENSG00000115524 SF3B1 AML 31921515
ENSG00000115524 SF3B1 Gastric Cancer 31927557
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000115524 SF3B1 myelodysplastic syndrome sequence_alteration 23.42% (869/3710) 6 entries
ENSG00000115524 SF3B1 Uveal Melanoma missense_variant 15.75% (89/565) 7 entries
ENSG00000115524 SF3B1 hemangioblastoma sequence_alteration 28.57% (10/35) 1 entry
ENSG00000115524 SF3B1 chronic lymphocytic leukemia missense_variant 12.59% (367/2916) 21 entries
ENSG00000115524 SF3B1 myelodysplastic syndrome missense_variant 23.42% (869/3710) 33 entries
ENSG00000115524 SF3B1 neoplasm missense_variant 29.36% (32/109) 2 entries
ENSG00000115524 SF3B1 mucosal melanoma missense_variant 23.61% (17/72) 2 entries
ENSG00000115524 SF3B1 chronic lymphocytic leukemia frameshift_variant 12.59% (367/2916) 1 entry
ENSG00000115524 SF3B1 myelodysplastic syndrome conservative_inframe_deletion 23.42% (869/3710) 3 entries
ENSG00000115524 SF3B1 chronic lymphocytic leukemia conservative_inframe_deletion 12.59% (367/2916) 4 entries
ENSG00000115524 SF3B1 Mixed Cell Uveal Melanoma missense_variant 21.88% (7/32) 3 entries
ENSG00000115524 SF3B1 basal cell carcinoma missense_variant 2.941% (2/68) 1 entry
ENSG00000115524 SF3B1 esophageal squamous cell carcinoma sequence_alteration 1.314% (9/685) 2 entries
ENSG00000115524 SF3B1 chronic myelomonocytic leukemia sequence_alteration 4.452% (37/831) 3 entries
ENSG00000115524 SF3B1 polycythemia vera missense_variant 1.29% (2/155) 1 entry
ENSG00000115524 SF3B1 Epithelioid Cell Uveal Melanoma missense_variant 13.64% (3/22) 2 entries
ENSG00000115524 SF3B1 chronic myelomonocytic leukemia missense_variant 4.452% (37/831) 8 entries
ENSG00000115524 SF3B1 non-small cell lung carcinoma missense_variant 2.74% (6/219) 4 entries
ENSG00000115524 SF3B1 salivary gland adenoid cystic carcinoma missense_variant 3.279% (2/61) 1 entry
ENSG00000115524 SF3B1 Breast Carcinoma by Gene Expression Profile missense_variant 1.352% (17/1257) 3 entries
ENSG00000115524 SF3B1 squamous cell lung carcinoma stop_gained 1.609% (15/932) 1 entry
ENSG00000115524 SF3B1 anaplastic oligodendroglioma missense_variant 2.247% (2/89) 1 entry
ENSG00000115524 SF3B1 breast phyllodes tumor missense_variant 2.609% (3/115) 3 entries
ENSG00000115524 SF3B1 Cervical Small Cell Carcinoma missense_variant 25.0% (2/8) 1 entry
ENSG00000115524 SF3B1 laryngeal squamous cell carcinoma missense_variant 4.878% (2/41) 2 entries
ENSG00000115524 SF3B1 Pleural Epithelioid Mesothelioma missense_variant 2.451% (5/204) 2 entries
ENSG00000115524 SF3B1 breast ductal adenocarcinoma missense_variant 2.712% (47/1733) 6 entries
ENSG00000115524 SF3B1 Endometrial Endometrioid Adenocarcinoma missense_variant 3.709% (24/647) 1 entry
ENSG00000115524 SF3B1 glioma missense_variant 0.5% (3/600) 1 entry
ENSG00000115524 SF3B1 esophageal squamous cell carcinoma missense_variant 1.314% (9/685) 5 entries
ENSG00000115524 SF3B1 Dysplasia in Ulcerative Colitis missense_variant 25.0% (2/8) 1 entry
ENSG00000115524 SF3B1 bile duct adenocarcinoma missense_variant 0.8977% (5/557) 1 entry
ENSG00000115524 SF3B1 nasopharyngeal squamous cell carcinoma missense_variant 0.974% (3/308) 2 entries
ENSG00000115524 SF3B1 acute myeloid leukemia missense_variant 2.676% (134/5007) 13 entries
ENSG00000115524 SF3B1 colon adenocarcinoma missense_variant 2.617% (34/1299) 8 entries
ENSG00000115524 SF3B1 lung adenocarcinoma missense_variant 1.812% (46/2538) 8 entries
ENSG00000115524 SF3B1 Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive missense_variant 8.333% (2/24) 2 entries
ENSG00000115524 SF3B1 prostate carcinoma missense_variant 1.171% (5/427) 2 entries
ENSG00000115524 SF3B1 skin melanoma stop_gained 3.323% (41/1234) 2 entries
ENSG00000115524 SF3B1 myelodysplastic syndrome stop_gained 23.42% (869/3710) 1 entry
ENSG00000115524 SF3B1 diffuse large B-cell lymphoma missense_variant 0.6803% (3/441) 3 entries
ENSG00000115524 SF3B1 central nervous system primitive neuroectodermal neoplasm missense_variant 0.8929% (4/448) 1 entry
ENSG00000115524 SF3B1 Invasive Breast Carcinoma missense_variant 6.383% (3/47) 1 entry
ENSG00000115524 SF3B1 Ampulla of Vater Carcinoma missense_variant 2.353% (2/85) 1 entry
ENSG00000115524 SF3B1 small cell lung carcinoma missense_variant 1.587% (7/441) 4 entries
ENSG00000115524 SF3B1 pancreatic ductal adenocarcinoma missense_variant 3.257% (58/1781) 4 entries
ENSG00000115524 SF3B1 T-cell acute lymphoblastic leukemia missense_variant 0.4813% (4/831) 2 entries
ENSG00000115524 SF3B1 prostate adenocarcinoma missense_variant 1.691% (41/2424) 5 entries
ENSG00000115524 SF3B1 bladder transitional cell carcinoma missense_variant 4.139% (19/459) 2 entries
ENSG00000115524 SF3B1 ulcerative colitis missense_variant 33.33% (3/9) 1 entry
ENSG00000115524 SF3B1 medullary thyroid gland carcinoma missense_variant 4.286% (3/70) 2 entries
ENSG00000115524 SF3B1 gastric adenocarcinoma missense_variant 1.281% (13/1015) 4 entries
ENSG00000115524 SF3B1 Breast Carcinoma by Gene Expression Profile sequence_alteration 1.352% (17/1257) 2 entries
ENSG00000115524 SF3B1 papillary thyroid carcinoma missense_variant 0.3945% (2/507) 2 entries
ENSG00000115524 SF3B1 Pleural Mesothelioma missense_variant 2.206% (3/136) 1 entry
ENSG00000115524 SF3B1 lobular breast carcinoma missense_variant 2.555% (7/274) 2 entries
ENSG00000115524 SF3B1 small intestinal adenocarcinoma missense_variant 9.524% (2/21) 1 entry
ENSG00000115524 SF3B1 squamous cell lung carcinoma missense_variant 1.609% (15/932) 2 entries
ENSG00000115524 SF3B1 breast carcinoma frameshift_variant 1.222% (22/1801) 2 entries
ENSG00000115524 SF3B1 female breast carcinoma missense_variant 1.205% (5/415) 2 entries
ENSG00000115524 SF3B1 urothelial carcinoma missense_variant 3.488% (3/86) 1 entry
ENSG00000115524 SF3B1 colon adenocarcinoma sequence_alteration 2.617% (34/1299) 1 entry
ENSG00000115524 SF3B1 esophageal adenocarcinoma missense_variant 2.194% (12/547) 2 entries
ENSG00000115524 SF3B1 diffuse gastric adenocarcinoma sequence_alteration 3.659% (3/82) 1 entry
ENSG00000115524 SF3B1 skin melanoma sequence_alteration 3.323% (41/1234) 1 entry
ENSG00000115524 SF3B1 brain glioblastoma missense_variant 0.6595% (8/1213) 2 entries
ENSG00000115524 SF3B1 Mast Cell Neoplasm missense_variant 2.632% (2/76) 1 entry
ENSG00000115524 SF3B1 colorectal adenocarcinoma sequence_alteration 2.508% (40/1595) 3 entries
ENSG00000115524 SF3B1 Uveal Melanoma conservative_inframe_deletion 15.75% (89/565) 1 entry
ENSG00000115524 SF3B1 melanoma missense_variant 3.448% (5/145) 3 entries
ENSG00000115524 SF3B1 breast carcinoma missense_variant 1.222% (22/1801) 3 entries
ENSG00000115524 SF3B1 cecum adenocarcinoma missense_variant 3.704% (10/270) 2 entries
ENSG00000115524 SF3B1 acute myeloid leukemia sequence_alteration 2.676% (134/5007) 1 entry
ENSG00000115524 SF3B1 skin melanoma missense_variant 3.323% (41/1234) 7 entries
ENSG00000115524 SF3B1 Myelodysplastic/Myeloproliferative Neoplasm missense_variant 4.938% (4/81) 3 entries
ENSG00000115524 SF3B1 rectal adenocarcinoma sequence_alteration 1.812% (10/552) 2 entries
ENSG00000115524 SF3B1 colorectal adenocarcinoma stop_gained 2.508% (40/1595) 1 entry
ENSG00000115524 SF3B1 Endometrial Endometrioid Adenocarcinoma sequence_alteration 3.709% (24/647) 1 entry
ENSG00000115524 SF3B1 Gallbladder Adenocarcinoma missense_variant 2.632% (5/190) 2 entries
ENSG00000115524 SF3B1 rectal adenocarcinoma missense_variant 1.812% (10/552) 4 entries
ENSG00000115524 SF3B1 bladder carcinoma missense_variant 4.1% (23/561) 1 entry
ENSG00000115524 SF3B1 essential thrombocythemia missense_variant 1.932% (4/207) 3 entries
ENSG00000115524 SF3B1 hepatocellular carcinoma missense_variant 0.9766% (10/1024) 2 entries
ENSG00000115524 SF3B1 clear cell renal carcinoma missense_variant 0.9472% (14/1478) 3 entries
ENSG00000115524 SF3B1 colorectal adenocarcinoma missense_variant 2.508% (40/1595) 2 entries
ENSG00000115524 SF3B1 acute myeloid leukemia amino_acid_insertion 2.676% (134/5007) 2 entries
ENSG00000115524 SF3B1 chronic myelogenous leukemia missense_variant 0.9009% (1/111) 1 entry
ENSG00000115524 SF3B1 leiomyosarcoma missense_variant 1.0% (1/100) 1 entry
ENSG00000115524 SF3B1 colon adenocarcinoma stop_gained 2.617% (34/1299) 1 entry
ENSG00000115524 SF3B1 Meningeal Melanocytoma missense_variant 2.632% (1/38) 1 entry
ENSG00000115524 SF3B1 synovial sarcoma missense_variant 2.381% (1/42) 1 entry
ENSG00000115524 SF3B1 anaplastic oligoastrocytoma missense_variant 2.439% (1/41) 1 entry
ENSG00000115524 SF3B1 Epithelioid Cell Uveal Melanoma conservative_inframe_deletion 13.64% (3/22) 1 entry
ENSG00000115524 SF3B1 Testicular Embryonal Carcinoma missense_variant 4.762% (1/21) 1 entry
ENSG00000115524 SF3B1 Primary Melanocytic Lesion of Meninges missense_variant 12.5% (1/8) 1 entry
ENSG00000115524 SF3B1 Myelodysplastic/Myeloproliferative Neoplasm sequence_alteration 4.938% (4/81) 1 entry
ENSG00000115524 SF3B1 brain glioblastoma sequence_alteration 0.6595% (8/1213) 1 entry
ENSG00000115524 SF3B1 small cell lung carcinoma stop_gained 1.587% (7/441) 1 entry
ENSG00000115524 SF3B1 bladder transitional cell carcinoma conservative_inframe_deletion 4.139% (19/459) 1 entry
ENSG00000115524 SF3B1 Fibrolamellar Carcinoma missense_variant 5.556% (1/18) 1 entry
ENSG00000115524 SF3B1 Hodgkins lymphoma missense_variant 3.125% (1/32) 1 entry
ENSG00000115524 SF3B1 prostate carcinoma sequence_alteration 1.171% (5/427) 1 entry
ENSG00000115524 SF3B1 Tonsillar Squamous Cell Carcinoma missense_variant 11.11% (1/9) 1 entry
ENSG00000115524 SF3B1 prostate carcinoma frameshift_variant 1.171% (5/427) 1 entry
ENSG00000115524 SF3B1 Granulocytic Sarcoma missense_variant 4.0% (1/25) 1 entry
ENSG00000115524 SF3B1 Duodenal Adenocarcinoma missense_variant 5.882% (1/17) 1 entry
ENSG00000115524 SF3B1 lobular breast carcinoma frameshift_variant 2.555% (7/274) 1 entry
ENSG00000115524 SF3B1 Chronic Eosinophilic Leukemia, Not Otherwise Specified missense_variant 50.0% (1/2) 1 entry
ENSG00000115524 SF3B1 clear cell renal carcinoma sequence_alteration 0.9472% (14/1478) 1 entry
ENSG00000115524 SF3B1 cecum adenocarcinoma stop_gained 3.704% (10/270) 1 entry
ENSG00000115524 SF3B1 follicular thyroid carcinoma missense_variant 1.449% (1/69) 1 entry
ENSG00000115524 SF3B1 rectal adenocarcinoma frameshift_variant 1.812% (10/552) 1 entry
ENSG00000115524 SF3B1 colon adenocarcinoma frameshift_variant 2.617% (34/1299) 1 entry
ENSG00000115524 SF3B1 lung adenocarcinoma conservative_inframe_deletion 1.812% (46/2538) 1 entry
ENSG00000115524 SF3B1 Gastrointestinal stromal tumor missense_variant 0.5952% (1/168) 1 entry
ENSG00000115524 SF3B1 Colorectal Neuroendocrine Tumor G1 missense_variant 20.0% (1/5) 1 entry
ENSG00000115524 SF3B1 head and neck squamous cell carcinoma missense_variant 0.159% (1/629) 1 entry
ENSG00000115524 SF3B1 lung adenocarcinoma stop_gained 1.812% (46/2538) 1 entry
ENSG00000115524 SF3B1 adenoid cystic carcinoma missense_variant 33.33% (1/3) 1 entry
ENSG00000115524 SF3B1 HER2 Positive Breast Carcinoma missense_variant 2.174% (3/138) 1 entry
ENSG00000115524 SF3B1 pharyngeal squamous cell carcinoma missense_variant 0.6993% (1/143) 1 entry
ENSG00000115524 SF3B1 bile duct adenocarcinoma sequence_alteration 0.8977% (5/557) 1 entry
ENSG00000115524 SF3B1 adenosquamous lung carcinoma missense_variant 4.545% (1/22) 1 entry
ENSG00000115524 SF3B1 benign blood vessel neoplasm missense_variant 25.0% (1/4) 1 entry
ENSG00000115524 SF3B1 Salivary Gland Small Cell Carcinoma missense_variant 100.0% (1/1) 1 entry
ENSG00000115524 SF3B1 large cell lung carcinoma missense_variant 5.263% (1/19) 1 entry
ENSG00000115524 SF3B1 Adrenal Gland Neuroblastoma sequence_alteration 3.333% (2/60) 1 entry
ENSG00000115524 SF3B1 Ocular Sebaceous Carcinoma missense_variant 4.348% (1/23) 1 entry
ENSG00000115524 SF3B1 gastric adenocarcinoma sequence_alteration 1.281% (13/1015) 1 entry
ENSG00000115524 SF3B1 mesonephric adenocarcinoma missense_variant 25.0% (1/4) 1 entry
ENSG00000115524 SF3B1 Chronic Neutrophilic Leukemia missense_variant 25.0% (1/4) 1 entry
ENSG00000115524 SF3B1 Breast Carcinoma by Gene Expression Profile frameshift_variant 1.352% (17/1257) 1 entry
ENSG00000115524 SF3B1 medulloblastoma missense_variant 4.167% (1/24) 1 entry
ENSG00000115524 SF3B1 Uterine Carcinosarcoma missense_variant 0.6757% (1/148) 1 entry
ENSG00000115524 SF3B1 cecum adenocarcinoma sequence_alteration 3.704% (10/270) 1 entry
ENSG00000115524 SF3B1 non-small cell lung carcinoma sequence_alteration 2.74% (6/219) 1 entry
ENSG00000115524 SF3B1 endometrial stromal sarcoma missense_variant 6.25% (1/16) 1 entry
ENSG00000115524 SF3B1 Adrenal Gland Neuroblastoma missense_variant 3.333% (2/60) 1 entry
ENSG00000115524 SF3B1 cervical adenocarcinoma missense_variant 25.0% (1/4) 1 entry
ENSG00000115524 SF3B1 small cell lung carcinoma sequence_alteration 1.587% (7/441) 1 entry
ENSG00000115524 SF3B1 bronchoalveolar adenocarcinoma missense_variant 4.545% (1/22) 1 entry
ENSG00000115524 SF3B1 T-cell acute lymphoblastic leukemia frameshift_variant 0.4813% (4/831) 1 entry
ENSG00000115524 SF3B1 acute myeloid leukemia transcript_ablation 2.676% (134/5007) 1 entry
ENSG00000115524 SF3B1 monoclonal B-cell lymphocytosis missense_variant 1.562% (1/64) 1 entry
ENSG00000115524 SF3B1 Merkel cell skin cancer missense_variant 1.064% (1/94) 1 entry
ENSG00000115524 SF3B1 esophageal squamous cell carcinoma stop_gained 1.314% (9/685) 1 entry
ENSG00000115524 SF3B1 Parotid Gland Adenoid Cystic Carcinoma missense_variant 7.143% (1/14) 2 entries
ENSG00000115524 SF3B1 ovarian clear cell adenocarcinoma missense_variant 2.041% (1/49) 1 entry
ENSG00000115524 SF3B1 osteosarcoma sequence_alteration 0.6579% (1/152) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000115524 SF3B1 CHOL 0.045 low
ENSG00000115524 SF3B1 PAAD 0.02 high
ENSG00000115524 SF3B1 LGG 0.0012 high
ENSG00000115524 SF3B1 HNSC 0.0012 low
ENSG00000115524 SF3B1 KIRP 0.019 high
ENSG00000115524 SF3B1 KICH 0.0065 high
ENSG00000115524 SF3B1 LUAD 0.0062 low
ENSG00000115524 SF3B1 PCPG 0.0012 high
ENSG00000115524 SF3B1 THYM 0.024 low
ENSG00000115524 SF3B1 UCS 0.04 high
ENSG00000115524 SF3B1 OV 0.019 low
ENSG00000115524 SF3B1 KIRC 0.0071 low
ENSG00000115524 SF3B1 PRAD 0.009 high
ENSG00000115524 SF3B1 BLCA 0.05 low
ENSG00000115524 SF3B1 LAML 0.0037 high
ENSG00000115524 SF3B1 GBM 0.014 low
ENSG00000115524 SF3B1 SKCM 0.00016 low
ENSG00000115524 SF3B1 LIHC 0.0058 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000115524 SF3B1 CESC Amp 1.353175 0.154286 0.546387 0.166102
ENSG00000115524 SF3B1 KIRP Amp 1.597657 0.090905 0.688447 0.180556
ENSG00000115524 SF3B1 HNSC Amp 0.925170 0.121931 0.483573 0.160920
ENSG00000115524 SF3B1 BLCA Del 0.673570 0.075892 0.358426 0.316176